Atlas Trials

Study of EQU-001 for Uncontrolled Focal Onset Seizures

Clinical trial NCT05473442 · TERMINATED

Trial details

NCT number
NCT05473442
Sponsor
Equilibre Biopharmaceuticals B.V.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Focal Onset Seizures
Start date
2022-12-27
Primary completion
2023-07-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.